IRIS UniCatt

Racioppi, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.744
NA - Nord America 6.894
AS - Asia 4.934
SA - Sud America 885
AF - Africa 166
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 32.656
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.564
US - Stati Uniti d'America 6.679
SG - Singapore 2.242
DE - Germania 1.895
CN - Cina 1.137
SE - Svezia 904
NL - Olanda 838
FR - Francia 724
BR - Brasile 714
UA - Ucraina 485
VN - Vietnam 428
GB - Regno Unito 348
IN - India 293
IE - Irlanda 216
ID - Indonesia 145
JP - Giappone 136
PL - Polonia 136
FI - Finlandia 129
RU - Federazione Russa 124
CA - Canada 120
HK - Hong Kong 110
CH - Svizzera 87
TR - Turchia 69
BD - Bangladesh 64
ES - Italia 64
AR - Argentina 63
MX - Messico 53
BE - Belgio 51
IQ - Iraq 47
ZA - Sudafrica 41
KR - Corea 30
PK - Pakistan 30
CI - Costa d'Avorio 25
EC - Ecuador 25
MA - Marocco 25
AT - Austria 24
CO - Colombia 24
AL - Albania 21
RO - Romania 21
AE - Emirati Arabi Uniti 18
AZ - Azerbaigian 18
IR - Iran 18
PH - Filippine 16
SA - Arabia Saudita 16
VE - Venezuela 16
EG - Egitto 15
AU - Australia 14
CL - Cile 14
GR - Grecia 13
IL - Israele 13
LT - Lituania 13
TN - Tunisia 13
JO - Giordania 12
MY - Malesia 12
NG - Nigeria 12
NP - Nepal 12
UZ - Uzbekistan 12
PE - Perù 10
CZ - Repubblica Ceca 9
CR - Costa Rica 8
TW - Taiwan 8
HU - Ungheria 7
PT - Portogallo 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
DZ - Algeria 6
EU - Europa 6
KE - Kenya 6
KG - Kirghizistan 6
LK - Sri Lanka 6
NZ - Nuova Zelanda 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
SN - Senegal 6
UY - Uruguay 6
BG - Bulgaria 5
BY - Bielorussia 5
HR - Croazia 5
IS - Islanda 5
LV - Lettonia 5
PY - Paraguay 5
SM - San Marino 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DK - Danimarca 4
ET - Etiopia 4
HN - Honduras 4
KW - Kuwait 4
LB - Libano 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
CV - Capo Verde 3
JM - Giamaica 3
LU - Lussemburgo 3
NI - Nicaragua 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BZ - Belize 2
Totale 32.611
Salva come PNG Salva come JPEG
Città #
Milan 1.312
Singapore 1.207
Rome 1.171
Chandler 988
Ashburn 753
San Jose 649
Naples 405
Jacksonville 264
Florence 249
Turin 238
Beijing 231
Los Angeles 213
Dublin 208
San Mateo 205
Bologna 188
Ann Arbor 169
Bari 157
Palermo 155
Ho Chi Minh City 147
Nanjing 147
New York 140
Wilmington 140
Jakarta 134
Lauterbourg 134
Catania 124
Genoa 118
Hanoi 106
Munich 103
Verona 103
Hong Kong 97
Frankfurt am Main 96
Hefei 96
The Dalles 91
Dearborn 90
São Paulo 87
Bremen 85
Nürnberg 85
Kraków 82
Tokyo 82
Boston 81
Nanchang 75
Woodbridge 75
Lawrence 71
Brescia 69
Moscow 69
Houston 64
Marseille 63
Redwood City 63
Padova 58
Cagliari 51
Dallas 50
Santa Clara 49
Venice 49
Seattle 48
Parma 46
Taranto 46
Hyderabad 43
Pescara 42
Bergamo 41
Perugia 41
Buffalo 40
Lancaster 39
Ottawa 39
Princeton 39
Reggio Emilia 39
Brussels 38
Chicago 38
Messina 38
Mountain View 36
Salerno 36
Cattolica 34
Fairfield 32
Livorno 32
Helsinki 31
Paris 31
Stockholm 31
London 30
Orem 30
Amsterdam 29
Atlanta 29
Lucca 29
Redmond 29
Tianjin 29
Kadoma 28
Falls Church 27
Modena 27
Toronto 27
Trieste 27
Kent 26
Kunming 26
Montreal 26
Monza 26
Rimini 26
Abidjan 25
Johannesburg 25
Novara 24
Seoul 24
Augusta 23
Chennai 22
Da Nang 22
Totale 13.452
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.943
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.221
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 943
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 610
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 427
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 357
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 326
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 324
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 317
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 248
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 237
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 231
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 216
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 203
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 202
The occult urothelial cancer 199
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 184
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 183
Haemodynamic changes detected during open prostatectomy and transurethral resection for benign prostatic hyperplasia 182
Male infertility: non-surgical therapy 179
[Overactive bladder syndrome: the social and economic perspective] 169
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 168
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 168
Imaging in prostate cancer diagnosis: present role and future perspectives 167
Size of Bladder Cancers: Correlation among Different Types of Measurement 167
Bladder and prostate metastasis from small cell lung cancer: a rare entity 167
Hot topics in urological health economics. A mini review 165
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 163
Therapeutic strategies in penile cancer: state of the art 162
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 160
Antibiotic prophylaxis in urology 160
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 160
Acid-base and electrolyte balance in urinary intestinal orthotopic reservoir: ileocecal neobladder compared with ileal neobladder 158
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 156
Advanced bladder cancer: New agents and new approaches. A review 155
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 155
Imaging of renal cell carcinoma: state of the art and recent advances 154
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 154
Imaging in prostate cancer staging: present role e future perspectives 153
NBI: results review 153
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 152
Long-term behaviour of secretory immunity in ileocecal and ileal orthotopic neobladders. 150
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 150
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 150
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 148
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 147
Advanced bladder cancer: New agents and new approaches. A review 147
[Innovative treatments of non muscle invasive bladder cancer] 147
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 142
Imaging in prostate cancer staging: present role and future perspectives 142
Circumcision: history, religion and law 140
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 140
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 139
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 138
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 138
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 137
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 136
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 136
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 133
Imaging of renal cell carcinoma: state of the art and recent advances 132
Mitomycin C: new strategies to improve efficacy of a well-known therapy 132
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 131
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 131
Perioperative Outcomes of Robotic Radical Prostatectomy with Hugo™ RAS versus daVinci Surgical Platform: Propensity Score-Matched Comparative Analysis 130
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 130
The occult urothelial cancer 130
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 128
Second-line intravesical therapy. What is the present role of device-assisted therapy? 127
Transalbugineal Artificial Urinary Sphincter: A Refined Implantation Technique to Improve Surgical Outcomes 126
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 126
Robot-Assisted Radical Prostatectomy Performed with the Novel Surgical Robotic Platform Hugo™ RAS: Monocentric First Series of 132 Cases Reporting Surgical, and Early Functional and Oncological Outcomes at a Tertiary Referral Robotic Center 124
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 124
Vitamin B12 and folic acid plasma levels after ileocecal and ileal neobladder reconstruction 123
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 123
Therapy for non-muscle invasive bladder cancer: HP-NAP 123
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 122
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 122
Imaging in prostate cancer diagnosis: present role and future perspectives 121
Simultaneous surgical management of renal cancer with atrial thrombotic extension and severe chronic coronary artery disease: a case report 118
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 116
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 115
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 113
Quality of life following urinary diversion: Orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors 110
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 109
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 109
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 109
Predictive Factors for Major Complications and Urological Cancer Diagnosis in Older Adults (≥80 Years) Admitted to the Emergency Department for Hematuria 105
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 105
Imaging of renal cell carcinoma: state of the art and recent advances. 104
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 104
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 103
Sports and Genitourinary Traumas 103
[Doping and urologic tumors] 102
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder Cancer 101
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 101
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 101
Totale 29.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.581
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 0 0 0 0 0 181 65
2021/20221.385 136 86 45 104 110 77 56 174 94 81 189 233
2022/20234.082 416 397 268 493 215 396 196 338 441 213 400 309
2023/20245.933 330 583 373 514 407 456 453 575 426 565 559 692
2024/20258.328 580 690 746 629 798 608 619 647 946 653 797 615
2025/20267.814 1.204 375 513 801 1.286 511 1.446 482 559 557 80 0
Totale 32.885